Burning Rock Biotech Ltd (BNR) stock is down -90.31% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BNR stock a score of 25 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 2. BNR's rank also includes a short-term technical score of 11.
BNR has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on BNR!
Burning Rock Biotech Ltd (BNR) stock is lower by -9.11% while the S&P 500 is down -0.53% as of 11:00 AM on Friday, Jul 1. BNR is down -$0.27 from the previous closing price of $2.91 on volume of 498,262 shares. Over the past year the S&P 500 is down -12.84% while BNR is down -90.31%. BNR lost -$1.27 per share in the over the last 12 months.
Click Here to get the full Stock Report for Burning Rock Biotech Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
